title: Bevacizumab (Avastin).
authors.affiliation: Genentech BioOncology, Middleton, OH, USA. gena@gene.com
authors.forename: Gena
authors.initials: G
authors.lastname: Middleton
authors.forename: Denise V
authors.initials: DV
authors.lastname: Lapka
mesh_terms: D000911:Antibodies, Monoclonal / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000451:nursing; D004334:Drug Administration Schedule; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D006801:Humans; D008657:Metabolic Clearance Rate; D024802:Nurse's Role; D009859:Oncology Nursing / Q000379:methods; D010353:Patient Education as Topic; D018579:Patient Selection
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab